Publication | Closed Access

NIR-II fluorescent nanoprobe-labeled lateral flow biosensing platform: A high-performance point-of-care testing for carcinoembryonic antigen

NanomedicineEngineeringBiosensing SystemsCancer DetectionNanobiotechnologyLab-on-a-chipCarcinoembryonic AntigenHigh-performance Point-of-care TestingBiomedical EngineeringNanosensorMolecular DiagnosticsRadiation OncologySingle-molecule Detection